A Case of Contact Allergic Dermatitis to Topical Minoxidil

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2021 Feb 10

PMID 33564516

Citations 6

Authors

Hessah BinJadeed

Almuntsrbellah M Almudimeegh

Shadn A Alomran

Abdullah H Alshathry

Affiliations

Soon will be listed here.

Abstract

Coincidental findings of hypertrichosis in patients on minoxidil led to the development of a topical minoxidil formulation which has been approved by the Food and Drug Administration for the treatment of female pattern hair loss, the most common cause for hair loss in women. The most common side effect of topical minoxidil is irritant contact dermatitis with the typical symptoms of itching and scaling. Most commonly, these symptoms are a result of an allergic reaction to propylene glycol, or less commonly, to minoxidil itself. We present a case of a 27-year-old woman who developed facial swelling following allergic contact dermatitis to minoxidil 5% foam.

Citing Articles

Network Pharmacology Reveals Roxb. Regulates MAPK and HIF-1 Pathways to Treat Androgenetic Alopecia.

Sintos A, Cabrera H Biology (Basel). 2024; 13(7).

PMID: 39056691 PMC: 11274231. DOI: 10.3390/biology13070497.

Cell Therapy for Androgenetic Alopecia: Elixir or Trick?.

Mao Y, Liu P, Wei J, Xie Y, Zheng Q, Li R Stem Cell Rev Rep. 2023; 19(6):1785-1799.

PMID: 37277541 PMC: 10390634. DOI: 10.1007/s12015-023-10532-2.

Topical Delivery of Atraric Acid Derived from with Enhanced Skin Permeation and Hair Regrowth Activity for Androgenic Alopecia.

Pulat S, Subedi L, Pandey P, Bhosle S, Hur J, Shim J Pharmaceutics. 2023; 15(2).

PMID: 36839662 PMC: 9960134. DOI: 10.3390/pharmaceutics15020340.

Acute Localized Exanthematous Pustulosis (ALEP) Caused by Topical Application of Minoxidil.

Makris M, Kanelleas A, Papapostolou N, Pisimisi M, Katoulis A J Clin Med. 2023; 12(3).

PMID: 36769479 PMC: 9917494. DOI: 10.3390/jcm12030831.

There Is a Positive Dose-Dependent Association between Low-Dose Oral Minoxidil and Its Efficacy for Androgenetic Alopecia: Findings from a Systematic Review with Meta-Regression Analyses.

Gupta A, Hall D, Talukder M, Bamimore M Skin Appendage Disord. 2022; 8(5):355-361.

PMID: 36161084 PMC: 9485924. DOI: 10.1159/000525137.

References

Karaoui L, Chahine-Chakhtoura C . Fatal toxic epidermal necrolysis associated with minoxidil. Pharmacotherapy. 2009; 29(4):460-7. DOI: 10.1592/phco.29.4.460. View

Weiss V, West D, Fu T, Robinson L, Cook B, Cohen R . Alopecia areata treated with topical minoxidil. Arch Dermatol. 1984; 120(4):457-63. View

Varothai S, Bergfeld W . Androgenetic alopecia: an evidence-based treatment update. Am J Clin Dermatol. 2014; 15(3):217-30. DOI: 10.1007/s40257-014-0077-5. View

Messenger A, Sinclair R . Follicular miniaturization in female pattern hair loss: clinicopathological correlations. Br J Dermatol. 2006; 155(5):926-30. DOI: 10.1111/j.1365-2133.2006.07409.x. View

Friedman E, Friedman P, Cohen D, Washenik K . Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. J Am Acad Dermatol. 2002; 46(2):309-12. DOI: 10.1067/mjd.2002.119104. View

Brough K, Torgerson R . Hormonal therapy in female pattern hair loss. Int J Womens Dermatol. 2017; 3(1):53-57. PMC: 5419033. DOI: 10.1016/j.ijwd.2017.01.001. View

Walsh D, Dunn C, James W . Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride. Arch Dermatol. 1995; 131(12):1373-5. View

Gungor S, Kocaturk E, Topal I . Frontal Edema Due to Topical Application of %5 Minoxidil Solution Following Mesotherapy Injections. Int J Trichology. 2015; 7(2):86-7. PMC: 4502485. DOI: 10.4103/0974-7753.160124. View

Sinclair R, Patel M, Dawson Jr T, Yazdabadi A, Yip L, Perez A . Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness. Br J Dermatol. 2011; 165 Suppl 3:12-8. DOI: 10.1111/j.1365-2133.2011.10630.x. View

10.

Vujovic A, Del Marmol V . The female pattern hair loss: review of etiopathogenesis and diagnosis. Biomed Res Int. 2014; 2014:767628. PMC: 4000932. DOI: 10.1155/2014/767628. View

11.

Degreef H, Hendrickx I . Allergic contact dermatitis to minoxidil. Contact Dermatitis. 1985; 13(3):194-5. DOI: 10.1111/j.1600-0536.1985.tb02542.x. View

12.

Levy L, Emer J . Female pattern alopecia: current perspectives. Int J Womens Health. 2013; 5:541-56. PMC: 3769411. DOI: 10.2147/IJWH.S49337. View

13.

Andersen M, Longhurst H, Rasmussen E, Bygum A . How Not to Be Misled by Disorders Mimicking Angioedema: A Review of Pseudoangioedema. Int Arch Allergy Immunol. 2016; 169(3):163-70. DOI: 10.1159/000445835. View

14.

Dinh Q, Sinclair R . Female pattern hair loss: current treatment concepts. Clin Interv Aging. 2007; 2(2):189-99. PMC: 2684510. View

15.

Messerli F . Vasodilatory edema: a common side effect of antihypertensive therapy. Am J Hypertens. 2001; 14(9 Pt 1):978-9. DOI: 10.1016/s0895-7061(01)02178-1. View

16.

Campese V . Minoxidil: a review of its pharmacological properties and therapeutic use. Drugs. 1981; 22(4):257-78. DOI: 10.2165/00003495-198122040-00001. View

17.

Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S . Minoxidil use in dermatology, side effects and recent patents. Recent Pat Inflamm Allergy Drug Discov. 2012; 6(2):130-6. DOI: 10.2174/187221312800166859. View